Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Chemotherapy (chemo) uses anti-cancer drugs that are most commonly given into a vein (IV) or given by mouth. These drugs travel through the bloodstream to all parts of the body. This makes chemo useful for treating cancers that have spread to other organs.
Chemo is most likely to be helpful for MCC that has spread to other organs. In the past, chemo was often the main treatment for MCC that had spread. But newer immunotherapy drugs tend to work better, so they are now more likely to be the first treatment for advanced cancers.
Chemo might still be used in some situations to treat advanced MCC, such as:
Merkel cell carcinoma (MCC) is rare, so it’s been hard to study the use of chemotherapy for MCC in clinical trials. Because of this, doctors often use chemo drugs that have been helpful in treating other types of fast-growing neuroendocrine tumors. The most commonly used drugs for MCCs that have spread include:
Most often, either cisplatin or carboplatin is used, often along with etoposide. Topotecan by itself tends to have fewer serious side effects, so it might be a better option for some people who are older or have serious health problems.
Another combination of drugs that may be used is called CAV, which includes cyclophosphamide, doxorubicin (Adriamycin), and vincristine.
These drugs are given intravenously (IV or into a vein), usually once every few weeks. They can often shrink MCC tumors for a time (or at least slow their growth and spread) and help relieve some symptoms. But after a while the cancer tends to start growing again.
Chemo drugs can cause side effects. These depend on the type and dose of the drugs given and how long they are used. Common side effects can include:
These side effects usually go away over time once treatment is finished.
Some drugs can have other effects that are not listed here, so be sure to talk with your cancer care team about what to expect.
There are often ways to lessen these side effects. For example, drugs can help prevent or reduce nausea and vomiting. Tell your cancer care team about any side effects or changes you notice while getting chemo so they can be treated right away, before they get worse.
For more general information about how chemotherapy is used to treat cancer, see Chemotherapy.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
National Cancer Institute. Merkel Cell Carcinoma Treatment (PDQ)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/skin/hp/merkel-cell-treatment-pdq on May 28, 2024.
National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Merkel Cell Carcinoma. Version 1.2024. Accessed at https://www.nccn.org on May 28, 2024.
Park SY, Nghiem PT, Tai P, Silk AW. Treatment of recurrent and metastatic Merkel cell carcinoma. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/treatment-of-recurrent-and-metastatic-merkel-cell-carcinoma on May 28, 2024.
Tai P, Park SY, Nghiem PT, Silk AW. Staging, treatment, and surveillance of locoregional Merkel cell carcinoma. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/staging-treatment-and-surveillance-of-locoregional-merkel-cell-carcinoma on May 28, 2024.
Last Revised: May 30, 2024
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.